Social Media Press Releases
RSSShowing Press Releases with Tag: asthma
10/30/2009
MedImmune to Present 4 Abstracts on RSV and Influenza at 47TH Annual IDSA Meeting
» read more6/01/2009
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
» read more5/05/2009
FluMist® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting
» read more10/24/2008
MedImmune to Present Nine Abstracts on RSV and Influenza at 48th Annual ICAAC/46th Annual IDSA Meeting
» read more5/05/2008
Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors’ Visits
» read more5/05/2008
Efficacy of FluMist(R) in Children Highlighted at Pediatric Academic Societies Meeting
» read more4/28/2008
Fourteen Abstracts Featuring MedImmune’s Influenza and RSV Therapeutic Areas to Be Presented at Pediatric Academic Societies Annual Meeting
» read more2/27/2008
MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
» read more12/07/2007
AstraZeneca Presents its Global Biologics Organisation, MedImmune, at 2007 Analyst and Investor R&D Day
» read more11/14/2007
The New England Journal of Medicine Publishes First Clinical Results for MedImmune’s Chitinase-like Protein YKL-40 in Patients With Asthma
» read more10/09/2007
Data from MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting
» read more9/19/2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
» read more9/07/2007
